Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

Market Cap	3.56B
Revenue (ttm)	502.96M
Net Income (ttm)	125.31M
Shares Out	149.91M
EPS (ttm)	0.83
PE Ratio	28.70
Forward PE	n/a
Dividend	0.11 (0.48%)
Ex-Dividend Date	May 20, 2025

Volume	1,191,479
Average Volume	1,768,281
Open	24.03
Previous Close	24.01
Day's Range	23.71 - 24.27
52-Week Range	20.01 - 33.31
Beta	0.78
RSI	42.43
Earnings Date	Oct 17, 2025

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Dongyang, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1998
• Employees: 663
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 001367

Financial Performance

In 2024, SHE:001367's revenue was 471.51 million, an increase of 18.63% compared to the previous year's 397.45 million. Earnings were 122.56 million, an increase of 17.09%.